Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.46 |
| ▸ | PLAU | P00749 | 2/20 | 0.46 |
| ▸ | KLKB1 | P03952 | 2/20 | 0.46 |
| ▸ | ELANE | P08246 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 2/20 | 0.41 |
| ▸ | NOS1 | P29475 | 1/20 | 0.40 |
| ▸ | NOS2 | P35228 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7759714 | 0.74 | — | — | |
| SCHEMBL28868986 | 0.74 | — | — | |
| SCHEMBL18463797 | 0.74 | — | — | |
| SCHEMBL9324320 | 0.74 | — | — | |
| SCHEMBL4184592 | 0.74 | — | — | |
| SCHEMBL9821780 | 0.74 | — | — | |
| SCHEMBL7114840 | 0.72 | F2 (0.53) | F2PLAUKLKB1ELANEKMT2A | |
| SCHEMBL20242142 | 0.71 | SMN1; SMN2 (0.48) | F2PLAUKLKB1ELANEPKM | |
| SCHEMBL9369399 | 0.71 | HTT (0.68) | F2PLAUKLKB1ELANEKMT2A | |
| SCHEMBL18464502 | 0.71 | F2 (0.44) | F2PLAUKLKB1ELANEPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119462505-A | Synthesis method of fluoro gem dinitropyrazole inner salt | 三峡大学 | 2025-02-18 | — | — | CN | claimed |
| CN-108610291-B | Preparation method of 3, 4-dinitropyrazole | 中北大学 | 2020-06-02 | — | — | CN | claimed |
| US-9746300-B1 | Voltage induced porosity in insensitive munition | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2017-08-29 | — | — | US | claimed |
| CN-105669557-A | High-selectivity and high-yield non-solvent preparation method of 1-methyl-3,4,5-trinitropyrazole (MTNP) intermediate 3,5-dinitropyrazole | 北京理工大学 | 2016-06-15 | — | — | CN | claimed |
| EP-2444807-B1 | MONO- AND DINITROPYRAZOLE HAPTEN CONJUGATES | VENTANA MED SYST INC (US) | 2014-06-11 | — | — | EP | claimed |
| EP-2444806-B1 | Haptens, hapten conjugates, compositions thereof and method for their preparation and use | VENTANA MED SYST INC (US) | 2014-05-28 | — | — | EP | claimed |
| CN-119462505-B | Synthesis method of fluoro gem dinitropyrazole inner salt | 三峡大学 | 2025-10-28 | — | — | CN | disclosed |
| CN-119462505-B | Synthesis method of fluoro gem dinitropyrazole inner salt | 三峡大学 | 2025-10-28 | — | — | CN | disclosed |
| CN-119462505-A | Synthesis method of fluoro gem dinitropyrazole inner salt | 三峡大学 | 2025-02-18 | — | — | CN | disclosed |
| CN-119462505-A | Synthesis method of fluoro gem dinitropyrazole inner salt | 三峡大学 | 2025-02-18 | — | — | CN | disclosed |
| CN-119462505-A | Synthesis method of fluoro gem dinitropyrazole inner salt | 三峡大学 | 2025-02-18 | — | — | CN | disclosed |
| US-20250042859-A1 | METHOD FOR PREPARING 3,5-DINITROPYRAZOLE | EURENCO (FR) | 2025-02-06 | — | — | US | disclosed |
| CN-119263939-A | Pyrazole/guanidine chimeric explosive and preparation method thereof | 中国工程物理研究院化工材料研究所 | 2025-01-07 | — | — | CN | disclosed |
| WO-2008153744-A2 | POLYMERIC CARRIERS FOR IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION | VENTANA MEDICAL SYSTEMS, INC. (US) | 2008-12-18 | — | — | WO | disclosed |
| WO-2008152525-A2 | DINITROPYRAZOLE DERIVATIVES, THEIR PREPARATION, AND ENERGETIC COMPOSITIONS COMPRISING THEM. | SNPE MATERIAUX ENERGETIQUES (FR) | 2008-12-18 | — | — | WO | disclosed |
| US-20080305497-A1 | Polymeric carriers for immunohistochemistry and in situ hybridization | VENTANA MEDICAL SYSTEMS, INC. | 2008-12-11 | — | — | US | disclosed |
| US-6706889-B1 | Dinitropyrazolopyrazole-amine salts useful in gun propellants | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2004-03-16 | — | — | US | disclosed |
| US-6069277-A | Amination of electrophilic aromatic compounds by vicarious nucleophilic substitution | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-05-30 | — | — | US | disclosed |
| EP-0835237-A1 | AMINATION OF ELECTROPHILIC AROMATIC COMPOUNDS BY VICARIOUS NUCLEOPHILIC SUBSTITUTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-04-15 | — | — | EP | disclosed |
| WO-1996035659-A1 | AMINATION OF ELECTROPHILIC AROMATIC COMPOUNDS BY VICARIOUS NUCLEOPHILIC SUBSTITUTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250042859-A1 | METHOD FOR PREPARING 3,5-DINITROPYRAZOLE | AP3S1, CYP3A43, CYP3A7 | F2 3492/4885PLAU 4694/4885KLKB1 4370/4885 |
| US-20080305497-A1 | Polymeric carriers for immunohistochemistry and in situ hybridization | FCGR2A, CD68, CA14 | F2 2802/4885PLAU 4170/4885KLKB1 3288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.